Health News of Alabama: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health News of Alabama.

Press releases published on November 5, 2026

16 minutes ago

Retension Pharmaceuticals to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference

Indeterminate GlobeNewswire

18 minutes ago

LightSolver Secures ~$1.8 Million Grant from Israel’s Innovation Authority to Advance its Laser Processing Unit (LPU)

Indeterminate GlobeNewswire

18 minutes ago

Taysha Gene Therapies to Release Third Quarter 2026 Financial Results and Host Conference Call and Webcast on November 12

Indeterminate GlobeNewswire

18 minutes ago

SpyGlass Pharma to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

18 minutes ago

Galectin Therapeutics Presents New Analyses on Noninvasive Prediction of Variceal Development from its Belapectin Development Program at AASLD Liver Meeting 2026

Indeterminate GlobeNewswire

18 minutes ago

Intellia Therapeutics Announces Third Quarter 2026 Financial Results and Business Updates

Indeterminate GlobeNewswire

18 minutes ago

Novastra Therapeutics Establishes Scientific Advisory Board and Appoints Senior Advisors and Head of Clinical Development

Indeterminate GlobeNewswire

18 minutes ago

Processa Pharmaceuticals to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

18 minutes ago

Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences in November

Indeterminate GlobeNewswire

18 minutes ago

Forward Therapeutics Announces U.S. FDA IND Clearance to Initiate Phase 2 Study of FT2109 in Psoriatic Arthritis

Indeterminate GlobeNewswire

18 minutes ago

Grace Therapeutics Announces Participation in Upcoming Industry and Investor Events in November 2026

Indeterminate GlobeNewswire

18 minutes ago

Incyclix Bio Establishes Steering Committee of Leading Breast Cancer Experts to Guide INX-315 Clinical Development

Indeterminate GlobeNewswire

18 minutes ago

Arcutis Begins Enrolling Phase 3 Study Evaluating ZORYVE® (roflumilast) Cream 0.3% in Moderate to Severe Atopic Dermatitis

Indeterminate GlobeNewswire

18 minutes ago

Nova Anchora Announces $23 Million Financing to Advance Topical Collagen VII Therapy for Dystrophic Epidermolysis Bullosa

Indeterminate GlobeNewswire

18 minutes ago

Ovid Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

18 minutes ago

PharmAla Signs Agreement and Initiates R&D with Corealis Pharma for GMP Manufacturing of its patented ALA-002 Drug Product

Indeterminate GlobeNewswire

18 minutes ago

Baird Medical and Alpmed Announce FDA 510(k) and EU CE Submissions for Irreversible Electroporation (IRE) System

Indeterminate GlobeNewswire

18 minutes ago

Immutep Announces Upcoming Poster Presentations at CTOS 2026 and ESMO Immuno-Oncology & Advanced Therapies Congress 2026

Indeterminate GlobeNewswire

18 minutes ago

Science 37 Named 2026 “BioTechnology Innovation of the Year” for its Direct-to-Patient Clinical Trial Delivery Model

Indeterminate GlobeNewswire

18 minutes ago

Shattuck Labs Reports Third Quarter 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire